In a paper published in the journal Cell, scientists describe unexpected, undesirable outcomes after editing genes in human embryos with CRISPR, a genomic editing system.
The study, the most detailed analysis to date of CRISPR in human embryos, shows that applying CRISPR to repair a blindness-causing gene early in the development of a human embryo often eliminates an entire chromosome or a large section of it.
"Our study shows that CRISPR/Cas9 is not yet ready for clinical use to correct mutations at this stage of human development," says the study's senior author.
The genome editing system called CRISPR/Cas9 has revolutionized molecular biology in recent years, and its discoverers were honored with this year's Nobel Prize in chemistry. The system allows scientists to make precise changes in the genomes of cultured cells, living tissues, and animal embryos.
The first use of CRISPR in human embryos was reported in 2015. Just a few years later in 2018, He Jiankui claimed to have performed the procedure in a pair of twins, eliciting a firestorm of condemnation from scientists and government officials worldwide.
In the new paper, the authors tested CRISPR/Cas9 genome editing's effects on early-stage human embryos carrying a mutation in a gene called EYS (eyes shut homolog), which causes hereditary blindness.
"We know from previous studies in differentiated human cells and in mice that a break in the DNA results in mostly two outcomes: precise repair or small local changes. At the EYS gene, these changes can yield a functional gene, though it is not a perfect repair," says the co-lead author of the paper.
When the authors looked at the entire genomes of the modified embryos in this study, they identified another outcome. "We learned that in human embryonic cells, a single break in the DNA can result a third outcome, the loss of an entire chromosome or sometimes a large segment of that chromosome, and this loss of the chromosome is very frequent," says the co-author.
In 2017, a study reported the successful correction of a heart disease-causing mutation in normal human embryos using CRISPR. Comprehensive data from the new study offer a different interpretation of these results: instead of being corrected, the chromosome carrying the mutation may have been lost altogether.
"If our results had been known two years ago, I doubt that anyone would have gone ahead with an attempt to use CRISPR to edit a gene in a human embryo in the clinic," the author says. "Our hope is that these cautionary findings should discourage premature clinical application of this important technology, but can also guide responsible research to achieve its ultimate safe and effective use."
https://www.cuimc.columbia.edu/news/study-identifies-pitfall-correcting-mutations-human-embryos-crispr
https://www.cell.com/cell/fulltext/S0092-8674(20)31389-1
Pitfall for correcting mutations in human embryos with CRISPR
- 1,415 views
- Added
Edited
Latest News
mtDNA transcription Inhibit…
By newseditor
Posted 09 May
A drug molecule targeting R…
By newseditor
Posted 09 May
Supramolecular anticoagulan…
By newseditor
Posted 09 May
Intron detention regulates…
By newseditor
Posted 09 May
New immunosuppressive mecha…
By newseditor
Posted 09 May
Other Top Stories
Why is it harder for females to gain weight?
Read more
Enduring cold temperatures alters fat cell epigenetics
Read more
Diabetes compound more effective by altering receptor trafficking
Read more
Pediatric obesity, depression connected in the brain
Read more
Implantable islet cells come with their own oxygen supply
Read more
Protocols
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
A validation strategy to as…
By newseditor
Posted 04 May
Publications
Inhibition of mammalian mtD…
By newseditor
Posted 09 May
Small-molecule inhibition o…
By newseditor
Posted 09 May
Rescue of Alzheimer's disea…
By newseditor
Posted 09 May
Transcriptomic, epigenomic,…
By newseditor
Posted 09 May
Development of supramolecul…
By newseditor
Posted 09 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar